233 related articles for article (PubMed ID: 16309423)
41. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay.
Pankuch GA; Hoellman DB; Lin G; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Nov; 42(11):3032-4. PubMed ID: 9797250
[TBL] [Abstract][Full Text] [Related]
42. [The postantibiotic effect of azithromycin on respiratory pathogens].
Diculencu D; Andrews JM; Boswell FJ; Wise R
Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):128-34. PubMed ID: 9455450
[TBL] [Abstract][Full Text] [Related]
43. Trends in the activity of macrolide and beta-lactam antibiotics and resistance development. Alexander Project Group.
Schito GC; Mannelli S; Pesce A
J Chemother; 1997 May; 9 Suppl 3():18-28. PubMed ID: 9248977
[TBL] [Abstract][Full Text] [Related]
44. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
Berry V; Thorburn CE; Knott SJ; Woodnutt G
Antimicrob Agents Chemother; 1998 Dec; 42(12):3193-9. PubMed ID: 9835514
[TBL] [Abstract][Full Text] [Related]
45. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
Johnson DM; Biedenbach DJ; Beach ML; Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 2000 Jun; 37(2):99-105. PubMed ID: 10863104
[TBL] [Abstract][Full Text] [Related]
46. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
47. Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect.
Boswell FJ; Andrews JM; Wise R
J Antimicrob Chemother; 1998 Feb; 41(2):149-53. PubMed ID: 9533455
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
Morrissey I; Robbins M; Viljoen L; Brown DF
J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
[TBL] [Abstract][Full Text] [Related]
49. [In vitro activity of telithromycin against community acquired respiratory pathogens].
Ulloa F MT; Camponovo C R; Fernández V A; García C P; Prado J V; González A P; Rojas S P; Inostroza S J; Lafourcade R M; Aguilera A L; Porte T L; Cruz P C; Joyas M A; Alcaide L B; Pinto C ME; Giglio M MS
Rev Med Chil; 2005 Apr; 133(4):419-25. PubMed ID: 15953948
[TBL] [Abstract][Full Text] [Related]
50. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
Melo-Cristino J; Fernandes ML; Serrano N;
Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
[TBL] [Abstract][Full Text] [Related]
51. [Activity of telithromycin and other oral antibiotics against respiratory tract pathogens with acquired mechanisms of resistance].
Gómez-Garcés JL; Alós JI; Hernáiz C; Gómez C
Enferm Infecc Microbiol Clin; 2004; 22(6):323-7. PubMed ID: 15228898
[TBL] [Abstract][Full Text] [Related]
52. Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000.
Critchley IA; Blosser-Middleton R; Jones ME; Yamakita J; Aswapokee N; Chayakul P; Tharavichitukul P; Vibhagool A; Thornsberry C; Karlowsky JA; Sahm DF
J Chemother; 2002 Apr; 14(2):147-54. PubMed ID: 12017369
[TBL] [Abstract][Full Text] [Related]
53. The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci.
Dunkin KT; Jones S; Howard AJ
J Antimicrob Chemother; 1988 Apr; 21(4):405-11. PubMed ID: 2837451
[TBL] [Abstract][Full Text] [Related]
54. Effect of telithromycin and azithromycin on nasopharyngeal bacterial flora in patients with acute maxillary sinusitis.
Brook I; Hausfeld JN
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):442-5. PubMed ID: 16618915
[TBL] [Abstract][Full Text] [Related]
55. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN
Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548
[TBL] [Abstract][Full Text] [Related]
56. In vitro activities of macrolides against gram-positive aerobes, Haemophilus influenzae, Moraxella catarrhalis and Bacteroides fragilis in Taiwan.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr; 62(4):230-5. PubMed ID: 10367484
[TBL] [Abstract][Full Text] [Related]
57. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.
Kays MB; Lisek CR; Denys GA
Int J Antimicrob Agents; 2007 Mar; 29(3):289-94. PubMed ID: 17240118
[TBL] [Abstract][Full Text] [Related]
58. Killing of Streptococcus pneumoniae by azithromycin, clarithromycin, erythromycin, telithromycin and gemifloxacin using drug minimum inhibitory concentrations and mutant prevention concentrations.
Blondeau JM; Shebelski SD; Hesje CK
Int J Antimicrob Agents; 2015 Jun; 45(6):594-9. PubMed ID: 25752567
[TBL] [Abstract][Full Text] [Related]
59. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393
[TBL] [Abstract][Full Text] [Related]
60. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
Mazzariol A; Koncan R; Bahar G; Cornaglia G
J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]